Results 81 to 90 of about 866,587 (181)

Assessment of HIV disease progression before and after initiation of anti­retroviral therapy by CD4 & CD8 T-lymphocyte count and viral load assay

Bangabandhu Sheikh Mujib Medical University Journal, 2016
Backgrounds: As there is no published data regarding the response to Anti-retroviral therapy (ART) among HIV patients from Bangladesh. The present study was designed to determine the immunological and virological responses of HIV infected Bangladeshi ...
Sahina Tabassum, S.M. Rashed-ul Islam, Afzalun Nessa, Munira Jahan, Saif Ullah Munshi   +4 more
doaj   +1 more source

Regression of canine oral papillomas is associated with infiltration of CD4+ and CD8+ lymphocytes [PDF]

, 2001
Canine oral papillomavirus (COPV) infection is used in vaccine development against mucosal papillomaviruses. The predictable, spontaneous regression of the papillomas makes this an attractive system for analysis of cellular immunity.
Nicholls, Philip K., Parry, N.R., Gough, Gerald W., Anderson, Davina M., Gough, G.W., Stanley, M.A., Parry, Nigel R., Stanley, Margaret A., Nicholls, P.K., Moore, Peter F., Moore, Richard A., Moore, R.A., Anderson, D.M., Moore, P.F.   +13 more
core   +1 more source

Mathematical predictive relationship of CD4+ lymphocytes and total leukocytes in HIV-infected patients

HIV & AIDS Review. International Journal of HIV-Related Problems
Introduction Different parameters have been established to direct the treatment of patients with human immunodeficiency virus (HIV) infection, such as CD4+ lymphocyte values, and it is of clinical interest to have methodologies that accurately predict ...
Signed Esperanza Prieto Bohorquez, Joao Cuesta, César Alejandro Valdés Cadena, Carlos Eduardo Pérez Díaz, Sandra Medina Araujo, Ribká Soracipa Muñoz, Andrés David Ibarra, Eduardo Méndez Pino, Sandra Catalina Correa Herrera, Javier Oswaldo Rodríguez Velasquez   +9 more
doaj   +1 more source

Real World Lab Data: Patterns of Lymphocyte Counts in Fingolimod Treated Patients

Frontiers in Immunology, 2018
Objective:Fingolimod is approved for the treatment of highly active relapsing remitting multiple sclerosis (MS) patients and acts by its unique mechanism of action via sphingosine-1-phosphate receptor-modulation.
Maxi Kaufmann, Rocco Haase, Undine Proschmann, Tjalf Ziemssen, Katja Akgün   +4 more
doaj   +1 more source

Laboratory and clinical predictors of disease progression following initiation of combination therapy in HIV-infected adults in Thailand [PDF]

, 2012
Background Data on determinants of long-term disease progression in HIV-infected patients on antiretroviral therapy (ART) are limited in low and middle-income settings. Methods Effects of current CD4 count, viral load and haemoglobin and diagnosis
Jourdain, G, Lallemant, Marc, Sudanee Buranabanjasatean, Jourdain, Gonzague, Duong, Trinh, Tansuphasawasdikul, Somboon, Ariyadej, S, Ngo-Giang-Huong, N, Sophie Le Cœur, Trinh Duong, Kantipong, P, Pacharee Kantipong, Duong, T, Somboon Tansuphasawasdikul, Nicole Ngo-Giang-Huong, Tansuphasawasdikul, S, Thongpaen, Suchart, Ariyadej, Sriprapar, Ariyadej, Seiprapar, Program for HIV Prevention and Treatment Study Group, Study Group, Program for HIV Prevention and Treatment (PHPT), Buranabanjasatean, Sudanee, Marc Lallemant, Leenasirimakul, P, Lallemant, M, Buranabanjasatean, S, Le Cœur, Sophie, Ngo-Giang-Huong, Nicole, Leenasirimakul, Prattana, Gonzague Jourdain, Suchart Thongpaen, Kantipong, Pacharee, Sriprapar Ariyadej, Prattana Leenasirimakul, Thongpaen, S, Le Cœur, S, Ariyadej Sriprapar, Tansuphasawasdikul Somboon, Ariyadej, S., Lallemant Marc, Jourdain Gonzague, Kantipong Pacharee, Duong, T., Buranabanjasatean Sudanee, Thongpaen Suchart, Le Cœur Sophie, Buranabanjasatean, S., Leenasirimakul, P., Kantipong, P., Leenasirimakul Prattana, Duong Trinh, Ngo-Giang-Huong Nicole, Tansuphasawasdikul, S., Thongpaen, S.   +53 more
core   +1 more source

Lymphocyte activation gene-3 : the expression and function in the immune system [PDF]

, 2006
Lymphocyte activation gene-3 (LAG-3) is the structural homologue of a well-known TCR co-receptor CD4. Recently, it has been suggested that LAG-3 might play a role in modulation of immune response, by being a negative regulator of T cell activation. To
Kisielow, Malgorzata
core   +1 more source

Mortality and its predictors among antiretroviral therapy naïve HIV-infected individuals with CD4 cell count ≥350 cells/mm(3) compared to the general population: data from a population-based prospective HIV cohort in Uganda. [PDF]

, 2014
BACKGROUND: Evidence exists that even at high CD4 counts, mortality among HIV-infected antiretroviral therapy (ART) naïve individuals is higher than that in the general population.
Masiira, Ben, Kaleebu, Pontiano, Kathy Baisley, Ben Masiira, Pontiano Kaleebu, Baisley, Kathy, Kazooba, Patrick, Billy N. Mayanja, Maher, Dermot, Patrick Kazooba, Mayanja, Billy N, Dermot Maher   +11 more
core   +1 more source

Recurring Candida albicans esophagitis in a HIV-infected patient undergoing long-Term antiretroviral therapy, and with absent-negligible immunodeficiency

Brazilian Journal of Infectious Diseases
A patient with HIV infection developed the first episode of AIDS-defining opportunism (severe Candida albicans esophagitis) with an underlying CD4+ lymphocyte count of 1,025 cells/µL.
Roberto Manfredi, Sergio Sabbatani, Leonardo Calza   +2 more
doaj   +1 more source

Correlation Between Total Lymphocyte Count and CD4 Lymphocyte Count in Children Infected with HIV [PDF]

, 2006
INTRODUCTION: As of the end of 2003, an estimated 42 million people worldwide - 38.6 million adults and 3.2 million children younger than 15 years - were living with HIV/AIDS. Approximately 70 percent of these people (29.4 million) live in Sub-Saharan
Chezhiyan, M
core  

HAART \u2013 Dependent CD4+ Lymphocyte Response Based on Pre-Therapeutic CD4 Lymphocyte Count in HIV-Infected Nigerians [PDF]

, 2006
Background: Increasing concerns related to cost, drug toxicity, pill burden, tolerability ability of patient to adhere to strict and complicated regimen and emergence of drug resistance has complicated the decision making process of when to start ...
Uko, E. K., Erhabor, O., Ejele, O. A.
core